Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PLEK - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZC2HC1A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
COQ9 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TNP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IDS - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ZNF259P1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
COX7A2L - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
C11orf95 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
INTS9 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MIR6840 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CRBN - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TP53I11 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HMGCL - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MPZL1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CRHR2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ASGR2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PRB3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FAM117A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IMPG2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HRH3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on